GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raffles Medical Group Ltd (SGX:BSL) » Definitions » EV-to-EBIT

Raffles Medical Group (SGX:BSL) EV-to-EBIT : 13.37 (As of May. 23, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Raffles Medical Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Raffles Medical Group's Enterprise Value is S$1,677.6 Mil. Raffles Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$125.5 Mil. Therefore, Raffles Medical Group's EV-to-EBIT for today is 13.37.

The historical rank and industry rank for Raffles Medical Group's EV-to-EBIT or its related term are showing as below:

SGX:BSL' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.17   Med: 22.97   Max: 33.84
Current: 13.37

During the past 13 years, the highest EV-to-EBIT of Raffles Medical Group was 33.84. The lowest was 9.17. And the median was 22.97.

SGX:BSL's EV-to-EBIT is ranked better than
65.73% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 18.045 vs SGX:BSL: 13.37

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Raffles Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was S$1,786.5 Mil. Raffles Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$125.5 Mil. Raffles Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.03%.


Raffles Medical Group EV-to-EBIT Historical Data

The historical data trend for Raffles Medical Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raffles Medical Group EV-to-EBIT Chart

Raffles Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.31 21.01 20.60 12.39 14.23

Raffles Medical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.60 - 12.39 - 14.23

Competitive Comparison of Raffles Medical Group's EV-to-EBIT

For the Medical Care Facilities subindustry, Raffles Medical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raffles Medical Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Raffles Medical Group's EV-to-EBIT falls into.



Raffles Medical Group EV-to-EBIT Calculation

Raffles Medical Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1677.577/125.517
=13.37

Raffles Medical Group's current Enterprise Value is S$1,677.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Raffles Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$125.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raffles Medical Group  (SGX:BSL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Raffles Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=125.517/1786.5098
=7.03 %

Raffles Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was S$1,786.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Raffles Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$125.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raffles Medical Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Raffles Medical Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Raffles Medical Group (SGX:BSL) Business Description

Traded in Other Exchanges
Address
585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The Hospital services segment provides medical services and operates hospitals, medical laboratories, and imaging centers. The Healthcare Services segment operates medical clinics and other general medical services, provides health insurance, trades pharmaceutical and nutraceutical products and diagnostic equipment, and provides management and consultancy services. The Investment holding segment involves investment in properties.